🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 8% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

46.5 Gram(s) Serving Size
18 Servings
Other Combinations Product Type
8% Evidence Coverage

Supplement Facts — Evidence Check

Calories
160 Calorie(s)
Total Fat
2.5 Gram(s) (4% DV)
Cholesterol
70 mg (23% DV)
Total Carbohydrates
5 Gram(s) (2% DV)
Protein
30 Gram(s) (60% DV)
Vitamin C
2 mg (3% DV)
Calcium
115 mg (12% DV)
Sodium
190 mg (8% DV)
2.5 Gram(s)
📊 Market median: 5.0mg (298 products) 📚 701 studies (Tier A: 5, B: 123)
This product: 2.5mg
2 Gram(s)
📊 Market median: 420.0mg (227 products)
Median 420.0mg This product: 2mg
Whey Protein Concentrate
Whey Protein Isolate

Other Ingredients

Natural & Artificial Flavors Cellulose Gum Xanthan Gum Protease Acesulfame Potassium Sucralose Protease A-S Lactase

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (98% of products) Structure/Function (93% of products) Nutrient (20% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

⚠️ Warnings & Precautions

Allergen warning: Milk and soy.

🧪 Formulation Notes

Complete performance All-in-one post workout 1 Pre 2 Post 3 All day

30 g protein 2.5 g creatine 2 g glutamine Vanilla naturally and artificially flavored

Gluten-free No soy protein isolate

Additional Information

From the makers of C4 America's #1 pre-workout brand

NSF Certified for Sport

Product Details

DSLD Entry Date 2024-05-23
Product Type Other Combinations
Form Powder
Brand Cellucor
DSLD ID 309674
Data Updated 2026-04-11

Research Evidence

739 Research Sources
47 Avg Quality Score
472 Clinical Trial
139 Meta Analysis
74 Systematic Review
47 Rct
2 Regulatory Source
1 Cochrane Review
1 Guideline
1 Openfda Safety
A Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data
Meta Analysis JAMA psychiatry 2021
A HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Meta Analysis The Cochrane database of systematic reviews 2014
A Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease
Meta Analysis The Cochrane database of systematic reviews 2014
B Greater Choline-Containing Compounds and Myo-inositol in Treatment-Resistant Versus Responsive Schizophrenia: A 1H-Magnetic Resonance Spectroscopy Meta-analysis
Meta Analysis Biological psychiatry. Cognitive neuroscience and neuroimaging 2024
B Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
Systematic Review BMC medicine 2019
B Efficacy of Creatine Supplementation Combined with Resistance Training on Muscle Strength and Muscle Mass in Older Females: A Systematic Review and Meta-Analysis
Meta Analysis Nutrients 2021
B The Effects of Creatine Supplementation on Upper- and Lower-Body Strength and Power: A Systematic Review and Meta-Analysis
Meta Analysis Nutrients 2025
B Meta-analysis of the efficacy and safety of Finerenone in diabetic kidney disease
Meta Analysis Medicine 2026
B Creatine and creatine analogues in hypertension and cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2011
B HMG CoA reductase inhibitors (statins) for dialysis patients
Meta Analysis The Cochrane database of systematic reviews 2013
View all evidence for Creatine →

Compare Similar Products

View all Creatine products →